Eftilagimod Alpha (Soluble LAG3 Protein) Combined with Pembrolizumab as Second-Line Therapy for Patients with Metastatic Head and Neck Squamous Cell Carcinoma
用户kXbnTIWMyBRM
1个月前
83
10
已完结
1. 系统已在2026-02-11 16:19:19对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1158/1078-0432.CCR-24-0473
其他信息:
出版社: American Association for Cancer Research (AACR)
作者: Martin Forster; Irene Brana; Antonio L. Pousa; Bernard Doger; Patricia Roxburgh; Pawan Bajaj; Julio Peguero; Matthew Krebs; Enric Carcereny; Grisma Patel; Christian Mueller; Chrystelle Brignone; Frederic Triebel
全文下载地址: https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-24-0473/3474882/ccr-24-0473.pdf
